Nicotine Replacement Therapy during Pregnancy and Child Health Outcomes: A Systematic Review
Open accessThe DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Abstract
Tobacco smoking in pregnancy is a worldwide public health problem. A majority of pregnant smokers need assistance to stop smoking. Most scientific societies recommend nicotine replacement therapy (NRT) during pregnancy but this recommendation remains controversial because of the known fetal toxicity of nicotine. The objective of this systematic review was to provide an overview of human studies about child health outcomes associated with NRT use during pregnancy. The electronic databases MEDLINE, the Cochrane Database, Web of Science, and ClinicalTrials.gov were searched from the inception of each database until 26 December 2020. A total of 103 articles were identified through database searching using combination of keywords. Out of 75 screened articles and after removal of duplicates, ten full-text articles were assessed for eligibility and five were included in the qualitative synthesis. NRT prescription seems to be associated with higher risk of infantile colic at 6 months as in case of smoking during pregnancy, and with risk of attention-deficit/hyperactivity disorder. No association between NRT during pregnancy and other infant health disorders or major congenital anomalies has been reported. Well-designed controlled clinical trials with sufficient follows-up are needed to provide more information on the use of NRT or other pharmacotherapies for smoking cessation during pregnancy on post-natal child health outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Widespread use of either noncombustible delivery systems is of great concern since these are not completely safe alternatives and result in detrimental health outcomes in the mother and children [9,10].”
From Nicotine on the developing brain. (2023) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Interventions for promoting smoking cessation during pregnancy
Lumley, J., Chamberlain, C., Dowswell, T., Oliver, S., Oakley, L., & Watson, L. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub3 · Cited by 890 · cited 1×
“Cessation of smoking during pregnancy benefits maternal and child health [3].”
BackgroundNicotine replacement therapy versus control for smoking cessation
Hartmann-Boyce, J., Chepkin, S. C., Ye, W., Bullen, C., & Lancaster, T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub5 · Cited by 697 · cited 1×
“Nicotine replacement therapy (NRT) has been demonstrated to help non-pregnant smokers to stop [8].”
BackgroundLange, S., Probst, C., Rehm, J., & Popova, S. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30223-7 · Cited by 550
Siu, A. L., & for the U.S. Preventive Services Task Force* (2015) · Annals of Internal Medicine · doi:10.7326/m15-2023 · Cited by 515 · cited 1×
“, potential benefits may warrant use of the drug in pregnant women despite potential risks) [16].”
BackgroundUS Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., et al. (2021) · JAMA · doi:10.1001/jama.2020.25019 · Cited by 512
Luck, W., Nau, H., Hansen, R., & Steldinger, R. (2017) · Developmental Pharmacology and Therapeutics · doi:10.1159/000457063 · Cited by 444 · cited 1×
“Nicotine easily crosses the placental barrier, and in humans it can be detected in the fetal circulation at levels exceeding its maternal concentrations by 15%; amniotic fluid concentrations of nicotine are 88% higher than maternal plasma nicotine concentrations [34,35].”
BackgroundPharmacological interventions for promoting smoking cessation during pregnancy
Coleman, T., Chamberlain, C., Davey, M.-A., Cooper, S. E., & Leonardi-Bee, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010078.pub2 · Cited by 357
Interventions for Tobacco Cessation in Adults, Including Pregnant Persons
Patnode, C. D., Henderson, J. T., Coppola, E. L., Melnikow, J., Durbin, S., & Thomas, R. G. (2021) · JAMA · doi:10.1001/jama.2020.23541 · Cited by 212 · cited 2×
“As of today, there is no evidence of increased risk of pregnancy or birth outcomes associated with the use of NRT [17,18].”
BackgroundSlotkin, T. A., Lappi, S. E., McCook, E. C., Lorber, B. A., & Seidler, F. J. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)00073-n · Cited by 191
A randomized trial of nicotine-replacement therapy patches in pregnancy.
Coleman, T., Cooper, S., Thornton, J. G., Grainge, M. J., Watts, K., Britton, J., & Lewis, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109582 · Cited by 190 · cited 1×
“The Smoking, Nicotine And Pregnancy (SNAP) trial was one of the few randomized controlled trial (RCT) assessing the efficacy of NRT during pregnancy; it included 521 women assigned to receive nicotine patches (15 mg per 16 h) or placebo patches (n = 529) [29].”
BackgroundPharmacological interventions for promoting smoking cessation during pregnancy
Claire, R., Chamberlain, C., Davey, M.-A., Cooper, S. E., Berlin, I., Leonardi-Bee, J., & Coleman, T. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010078.pub3 · Cited by 188 · cited 1×
“In pregnant smokers, literature data show that the prescription of NRT during pregnancy is not associated with smoking cessation during pregnancy or at the end of pregnancy if one considers randomized placebo controlled studies versus placebo [9,10].”
BackgroundSelf-citationAbbott, L. C., & Winzer-Serhan, U. H. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.658506 · Cited by 170
Parent-Completed Developmental Screening in Premature Children: A Valid Tool for Follow-Up Programs
Flamant, C., Branger, B., Tich, S. N. T., Rochebrochard, É. D. L., Savagner, C., Berlie, I., & Rozé, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020004 · Cited by 144 · cited 1×
“It seems that potential social and cultural differences between parents are not factors deemed to alter the validity of their neurologic assessment of their child [42].”
BackgroundPerinatal exposure to nicotine causes deficits associated with a loss of nicotinic receptor function
Cohen, G., Roux, J.-C., Grailhe, R., Malcolm, G., Changeux, J.-P., & Lagercrantz, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409782102 · Cited by 134
Prenatal nicotine exposure and cognitive performance in rats
Levin, E. D., Briggs, S. J., Christopher, N. C., & Rose, J. E. (1993) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(93)90006-a · Cited by 130 · cited 1×
“Cognitive impairments after prenatal exposure to nicotine have been demonstrated in animals and seem to stretch into adulthood [14,15].”
BackgroundParental smoking during pregnancy and ADHD in children: the Danish national birth cohort.
Zhu, J. L., Olsen, J., Liew, Z., Li, J., Niclasen, J., & Obel, C. (2014) · Pediatrics · doi:10.1542/peds.2014-0213 · Cited by 116 · cited 4×
“Some authors speculate that if higher doses of nicotine are needed during pregnancy to successfully quit smoking, this may contribute to the fetal toxicity of NRT described in animal studies, and can even contribute to the increased risk of attention deficit hyperactivity disorder associated with maternal smoking duri…”
BackgroundInfluentialPastrakuljic, A., Schwartz, R. M., Simone, C., Derewlany, L. O., Knie, B., & Koren, G. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00522-0 · Cited by 107 · cited 1×
“Nicotine easily crosses the placental barrier, and in humans it can be detected in the fetal circulation at levels exceeding its maternal concentrations by 15%; amniotic fluid concentrations of nicotine are 88% higher than maternal plasma nicotine concentrations [34,35].”
BackgroundCooper, S., Lewis, S., Thornton, J. G., Marlow, N., Watts, K., Britton, J., Grainge, M. J., Taggar, J., Essex, H., Parrott, S., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18540 · Cited by 103 · cited 2×
“This study also provided data on 2-years-old infants born to participating women (follow-up of 888 infants of the 1010 singleton neonates) in seven antenatal hospitals in the Midlands and North-West England [25,30].”
BackgroundFalk, L. L., Nordberg, A. K., Seiger, Å., Kjældgaard, A., & Hellström‐Lindahl, E. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.049 · Cited by 84 · cited 1×
“Nicotine is a neurotoxin and may affect development of fetal nerve tissues and brain development [11,12].”
BackgroundPrenatal nicotine exposure increases connective tissue expression in foetal monkey pulmonary vessels
Sekhon, H. S., Proskocil, B. J., Clark, J. A., & Spindel, E. R. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00069604 · Cited by 81 · cited 1×
“Animal studies have reported association between nicotine administration and abnormal lung development, leading to structural and functional alterations that persist into adulthood [39,40].”
BackgroundCooper, S., Taggar, J., Lewis, S., Marlow, N., Dickinson, A., Whitemore, R., & Coleman, T. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70157-2 · Cited by 73
Association between nicotine replacement therapy use in pregnancy and smoking cessation
Brose, L. S., McEwen, A., & West, R. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.04.017 · Cited by 62 · cited 1×
“The combination of NRT, which could be associated with higher odds of smoking cessation [41] should also be studied.”
BackgroundHellström‐Lindahl, E., Seiger, Å., Kjældgaard, A., & Nordberg, A. K. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00209-3 · Cited by 57 · cited 1×
“Nicotine is a neurotoxin and may affect development of fetal nerve tissues and brain development [11,12].”
BackgroundNicotine replacement therapy in pregnancy
Coleman, T., Britton, J., & Thornton, J. (2004) · BMJ · doi:10.1136/bmj.328.7446.965 · Cited by 55 · cited 1×
“Therefore, the general view is that NRT during pregnancy is safer than smoking [19].”
BackgroundGenedani, S., Bernardi, M., & Bertolini, A. (1983) · Psychopharmacology · doi:10.1007/bf00427504 · Cited by 46 · cited 1×
“Cognitive impairments after prenatal exposure to nicotine have been demonstrated in animals and seem to stretch into adulthood [14,15].”
BackgroundNicotine replacement therapy in pregnancy and major congenital anomalies in offspring.
Dhalwani, N. N., Szatkowski, L., Coleman, T., Fiaschi, L., & Tata, L. J. (2015) · Pediatrics · doi:10.1542/peds.2014-2560 · Cited by 45 · cited 7×
“According to one report, NRT exposure during pregnancy was not associated with major congenital anomalies in comparison with a control group (no NRT and no smoking during pregnancy) [27].”
BackgroundMethodInfluentialDescription of tobacco addiction in pregnant women
Grangé, G., Vayssière, C., Borgne, A., Ouazana, A., L’Huillier, J.-P., Valensi, P. E., Peiffer, G., Aubin, H., Renon, D., Thomas, D., et al. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.09.002 · Cited by 35
Havard, A., Jorm, L. R., Preen, D., Daube, M., Kemp, A., Einarsdóttir, K., Randall, D., & Tran, D. T. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003692 · Cited by 33 · cited 1×
“In 2013, the protocol of an Australian population-based cohort study using linked administrative data has been reported, the Maternal Use of Medications and Safety (MUMS) Smoking Study [7].”
MethodPetre, M. A., Petrik, J., Ellis, R., Inman, M. D., Holloway, A. C., & Labiris, N. R. (2011) · International Journal of Toxicology · doi:10.1177/1091581810395332 · Cited by 32 · cited 1×
“Animal studies have reported association between nicotine administration and abnormal lung development, leading to structural and functional alterations that persist into adulthood [39,40].”
BackgroundNicotine Replacement Therapy During Pregnancy and Infantile Colic in the Offspring
Milidou, I., Henriksen, T. B., Jensen, M. S., Olsen, J., & Søndergaard, C. (2012) · Pediatrics · doi:10.1542/peds.2011-2281 · Cited by 29 · cited 4×
“The results about infantile colic need to be confirmed because of the limitations of the related study [24].”
BackgroundInfluentialIs it safe to use smoking cessation therapeutics during pregnancy?
De Long, N. E., Barra, N. G., Hardy, D. B., & Holloway, A. C. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.973846 · Cited by 23
Diguisto, C., & Dochez, V. (2020) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2020.03.025 · Cited by 21
Kapaya, M., Tong, V. T., & Ding, H. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.07.008 · Cited by 19
Grangé, G., Berlin, I., Bretelle, F., Bertholdt, C., Berveiller, P., Blanc, J., Diguisto, C., Dochez, V., Garabédian, C., Guerby, P., et al. (2020) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2020.04.005 · Cited by 19
Self-citationFetal exposure to tobacco: nicotine and cotinine concentration in amniotic fluid and maternal saliva
Jacob, N., Golmard, J., & Berlin, I. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2016.1169523 · Cited by 16 · cited 1×
“Nicotine’s metabolism is largely reduced in fetal tissues in particular in the liver that may lead to the increased and long-lasting nicotine concentration in both fetal blood and amniotic fluid [36].”
BackgroundSelf-citationIyen, B., Vaz, L. R., Taggar, J., Cooper, S. E., Lewis, S., & Coleman, T. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024923 · Cited by 8 · cited 5×
“The SNAP RCT provided the highest level of evidence about infant outcomes at the age of 2 years old [25,26].”
BackgroundMethodInfluentialBlanc, J., & Koch, A. (2020) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2020.03.030 · Cited by 8
Self-citationBerveiller, P., Guerby, P., & Rault, E. (2020) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2020.03.023 · Cited by 5
Janssen, R., & Oudijk, M. A. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.10.023 · Cited by 2 · cited 1×
“The use of NRT during pregnancy has been controversial because of potential long-term pulmonary consequences based on animal studies [13].”
Background
Cited by
Nicotine on the developing brain.
Castro, E. M., Lotfipour, S., & Leslie, F. M. (2023) · Pharmacological research · doi:10.1016/j.phrs.2023.106716 · Cited by 157
Rábade, C., de Granda‐Orive, J. I., Riesco-Miranda, J. A., de Higes-Martínez, E., Pinedo, Á. R., Cabrera-César, E., Miñana, J. S.-C., García-Rueda, M., Esplá, E. P., & Jimenez-Ruiz, C. A. (2023) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2023.07.024 · Cited by 42
Pesola, F., Smith, K. M., Phillips‐Waller, A., Przulj, D., Griffiths, C., Walton, R., McRobbie, H., Coleman, T., Lewis, S., Whitemore, R., et al. (2024) · Addiction · doi:10.1111/add.16422 · Cited by 29
Vaping during pregnancy: a systematic review of health outcomes.
Ussher, M., Fleming, J., & Brose, L. (2024) · BMC pregnancy and childbirth · doi:10.1186/s12884-024-06633-6 · Cited by 27
“Systematic reviews and meta-analyses conclude that there is unclear evidence on whether the use of NRT during pregnancy is harmful to the fetus [20, 21].”
BackgroundSafety of Nicotine Replacement Therapy during Pregnancy: A Narrative Review
Morales‐Suárez‐Varela, M., Puig, B. M., Kærlev, L., Peraita‐Costa, I., & Alfredo Perales, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010250 · Cited by 18
Metadata
- Authors
- Blanc, J., Tosello, B., Ekblad, M. O., Berlin, I., & Netter, A.
- Affiliations
- Aix-Marseille Université (FR)
- Centre National de la Recherche Scientifique (FR)
- University of Turku (FI)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Blanc, Julie
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2021-04-11
- Volume
- 18
- Issue
- 8
- Pages
- 4004
- ISSN
- 1660-4601 (ISSN-L)
- PMC
- PMC8070414
- OpenAlex
- W3154152217
- Cited by
- 20
- References
- 42
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 7 · 2023: 4 · 2022: 3 · 2021: 1
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Environmental Research and Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, cc-by)
- HAL (submittedVersion, other-oa)
- IRIS (submittedVersion, cc-by)
- UTUPub (University of Turku) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- nicotine replacement therapy, pregnancy, smoking cessation, smoking during pregnancy, infant outcomes, infantile colic, attention deficit hyperactivity disorder, congenital malformations
- MeSH terms
- Child Health, Child, Female, Humans, Nicotine, Pregnancy, Smoking, Smoking Cessation, Tobacco Use Cessation Devices
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
